ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody ISAC Programs
August 27, 2021Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems, and Innovent Biologics. -
Genmab, Bolt ink deal to develop bispecific immune-stimulating antibody conjugates
June 03, 2021Genmab entered into an agreement with Bolt Biotherapeutics to develop next-generation, immune-stimulatory, antibody-based conjugate therapeutics for the treatment of cancer, the companies announced Wednesday.
Pharma Sources Insight January 2025
